FOLDERS. Alzheimer’s: a new treatment brings hope
the essential On January 6, the Food and Drug Administration -the US drug authority- gave its approval for the marketing of a new treatment based on monoclonal antibodies: lecanemab. This drug, which slows the cognitive deterioration of patients with Alzheimer’s disease, in a mild phase. For decades it was considered an incurable pathology and difficult …
FOLDERS. Alzheimer’s: a new treatment brings hope Read More »